ADMA Biologics Competitors and Similar CompaniesClear all
CorMedix's competitors and similar companies include Autolus and Array BioPharma.
 CorMedix CorMedix is a pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the treatment of cardiac and kidney disease. |  Autolus Autolus Therapeutics is a private biopharmaceutical company, focused on the development and commercialization of engineered T-cell immunotherapy products. |  Array BioPharma Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. | |
Founding Date | Founding Date 2006 | Founding Date 2014 | Founding Date 1998 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Berkeley Heights, US HQ | Locations London, GB HQ London, GB | Locations Boulder, US HQ Chicago, US Detroit, US Houston, US Miami, US New York, US Phoenix, US |
Employees | Employees 3036% increase | Employees 647 | Employees 110 |
Valuation ($) | Valuation ($) 749.2 m | Valuation ($) 1.2 b | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $311.7m (FY, 2025) | Revenue (est.) $75.4m (FY, 2025) | Revenue (est.) $173.8m (FY, 2018) |
Cost of goods | Cost of goods $22.1m (FY, 2025) | Cost of goods $86.6m (FY, 2025) | Cost of goods $59.4m (FY, 2018) |
Gross profit | Gross profit $275.7m (FY, 2025) | Gross profit ($10.7m) (FY, 2025) | Gross profit $114.4m (FY, 2018) |
Net income | Net income $163.1m (FY, 2025) | Net income ($287.5m) (FY, 2025) | Net income ($147.7m) (FY, 2018) |
Funding | |||
Total funding raised | Total funding raised $ 11.5m | Total funding raised $ 281.7m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Autolus
HQ
London, GB
Employees
647
Autolus Therapeutics is a private biopharmaceutical company, focused on the development and commercialization of engineered T-cell immunotherapy products.
View companyArray BioPharma
HQ
Boulder, US
Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.
View company